Even though the Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE)–BioNTech (NASDAQ: BNTX) vaccines have been authorized for emergency use by the U.S. Food & Drug Administration, we still have plenty of questions. How long will the immunity that they confer actually last? Will the vaccines protect against different mutations or strains of the virus? Dr. Bruce Gellin of the Sabin Vaccine Institute joined Olivia Zitkus and Corinne Cardina of the Fool.com Healthcare and Cannabis Bureau on a Dec. 18 episode of Fool Live to answer these questions and more.
Vaccination Expert: What Investors Should Watch In 2021
Latest from Blog
Could a small health insurer be similar to a spaceflight company? Social Capital CEO founder Chamath…
Despite the success of its COVID-19 vaccine program, Pfizer (NYSE: PFE) didn’t impress investors with its…
If growth and value investing were people, Growth would be the extroverted friend who’s mostly a…
A rejuvenated Intel (NASDAQ: INTC) had an interesting two days on Thursday and Friday of last…
Working in retirement might sound a little like an oxymoron, but it’s a reality for many…